Comparing two treatments for worsening stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether adding carbon dioxide (CO2) to the standard medicine phenylephrine is better than phenylephrine alone for people whose stroke symptoms are getting worse. The goal is to see if the combination treatment helps improve blood flow to the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older
- You have had a stroke that is getting worse (e.g., your weakness or speech problems are increasing)
- You are able to receive treatment with carbon dioxide (CO2) and the medicine phenylephrine
- You are not pregnant and do not have certain heart or kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether carefully lowering blood pressure after a mechanical clot removal procedure for stroke can improve outcomes. If you've had a large vessel stroke that was successfully treated with thrombectomy, this study will help guide blood pressure management in the recovery period.
This trial tests whether a combination of two medicines (chlorpromazine and promethazine) can safely induce a hibernation-like state in people having a severe stroke caused by a large clot in the front part of the brain. Participants will receive this therapy along with standard clot removal procedures to see if it helps protect the brain.
This trial tests a new approach to restore blood flow in the brain after a stroke. It aims to improve recovery and brain function in people with a blocked large artery.
This study tests a new drug called NoNO-42 for people having a moderate to severe ischemic stroke. You can join if you get clot-busting medicine within 4.5 hours of your stroke and may also have a procedure to remove the clot.
This trial tests whether a medication called butylphthalide can help reduce brain swelling that sometimes occurs after emergency endovascular treatment (a minimally invasive procedure to restore blood flow) for certain types of stroke.
This trial tests whether a simple remote “arm conditioning” treatment started soon after an acute ischemic stroke can improve outcomes and safety. It may help some patients recover better by supporting the body’s protective response to stroke.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.